Drug or treatment

Zasocitinib clinical trials

As of November 12, 2026, Find a Trial lists 4 clinical trials of Zasocitinib that are recruiting, at sites in 24 countries (most in Germany (3), Poland (3), Spain (3)). By phase: Phase 3 (3), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Zasocitinib (TAK-279) in adults with active Crohn’s disease Phase 2 Oxford Recruiting Feb 11, 2026
Continued daily zasocitinib treatment for adults with psoriatic arthritis Phase 3 Tucson, Arizona and 77 other locations Recruiting Dec 16, 2025
Long-term zasocitinib treatment for children and teenagers with plaque psoriasis Phase 3 Chula Vista, California and 38 other locations Recruiting Nov 26, 2025
Testing Zasocitinib for Psoriatic Arthritis in Adults Phase 3 Chandler, Arizona and 187 other locations Recruiting Nov 4, 2024

All recruiting trials (4)

Quick answers

How many clinical trials of Zasocitinib are recruiting right now?

4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 24 countries. The most sites are in Germany (3 trials), Poland (3 trials), Spain (3 trials), United States (3 trials), China (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 3, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.